Pioneering TechBio Solutions in Drug Discovery | Recursion
Our data and the Recursion OS enable us to train intelligent machine learning models for drug discovery and development, which help us rapidly identify new targets and design highly …
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …
Recursion Pharmaceuticals, Inc.
Jun 6, 2025 · By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the …
Press Releases & Recursion News | Recursion
Apr 3, 2025 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!
Recursion Pharmaceuticals, Inc. - Recursion and Exscientia Enter ...
Aug 8, 2024 · Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
Careers at Recursion: Join Our Mission | Recursion
Recursion is a clinical stage TechBio company decoding biology to industrialize drug discovery. Recursion is proudly headquartered in Salt Lake City, Utah. We're working to solve some of …
Recursion Reports First Quarter 2025 Financial Results and …
May 5, 2025 · Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry …
Technology - Recursion
Generating one of the largest relatable data sets in pharma is only possible with Recursion’s automated high throughput labs. We’ve generated ~36 PB of proprietary data across …
Recursion to Report Fourth Quarter and Fiscal Year 2024 Business ...
Feb 24, 2025 · Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry …
Recursion Pharmaceuticals, Inc. - Presentations
Dec 10, 2024 · Recursion's CCM Ph2 Data Webinar (SYCAMORE Trial) JP Morgan Conference 2025. January 13, 2025. Download 6.1 MB. REC-617 Interim Phase 1 Data Webinar . …